Grifols USA LLC

Los Angeles, CA

UEI
D48FNWJCJ5H5
CAGE
1N5P5
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2410 Grifols Wy, Los Angeles, CA 90032, USA
Website
grifols.com
Founded
1940
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Grifols USA LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Prolastin-c liquid,human 1000MG/VIL. Contract · 36C26026F0037 Veterans Integrated Service Network 20 $364,000
Pharm - prolastin-c Contract · 36C26026F0019 Veterans Integrated Service Network 20 $111,000
Pharm - prolastin-c Contract · 36C26026F0015 Veterans Integrated Service Network 20 $120,000
Prolastin-c liquid,human 1000MG/VIL Contract · 36C26025F0153 Veterans Integrated Service Network 20 $97,176
Prolastin-c bulk pharmacy Contract · 36C26025F0037 Veterans Integrated Service Network 20 $0

About Grifols USA LLC

Grifols USA LLC is a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. Registered in the System for Award Management (SAM) since 2001, the company is a for-profit organization that operates as a manufacturer of goods and holds multiple federal contract vehicles. Grifols focuses primarily on producing specialized pharmaceutical products, with a notable emphasis on PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency.

Through its federal contract awards, Grifols USA LLC has consistently supplied critical pharmaceutical products to various federal agencies, predominantly the Department of Veterans Affairs (VA), Centers for Disease Control and Prevention (CDC), and Department of Justice's Bureau of Prisons. The company's contract awards have been predominantly delivery orders for PROLASTIN-C LIQUID and other specialized medications, with contract values ranging from approximately $10,000 to over $500,000. These contracts are consistently awarded on a firm fixed-price basis and do not utilize set-aside designations, indicating Grifols' status as a large, capable business able to meet federal healthcare procurement needs. The majority of these contracts are issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance locations spanning multiple VA Veterans Integrated Service Networks and federal medical facilities across the United States.

Grifols USA LLC holds several significant indefinite delivery vehicles (IDVs) that demonstrate its critical role in federal healthcare supply chains. These include a $1.38 billion Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs, a $107.5 million Blanket Purchase Agreement specifically for PROLASTIN-C, and multiple CDC contracts for vaccine supply. The CDC contracts are particularly noteworthy, including a $13.88 million annual contract for the Vaccines for Children (VFC) program and additional contracts for adult vaccines covering hepatitis, pneumococcal, tetanus, diphtheria, herpes zoster, and other critical immunizations. These IDVs span multiple years, with performance periods typically ranging from one to three years, and allow federal agencies to efficiently procure essential medical supplies through established contract vehicles without repetitive solicitations.

Contract vehicles

Quick answers

What is Grifols USA LLC's UEI?

Grifols USA LLC's Unique Entity ID (UEI) in SAM.gov is D48FNWJCJ5H5.

What is Grifols USA LLC's CAGE code?

Grifols USA LLC's CAGE code is 1N5P5.

What is Grifols USA LLC's primary NAICS code?

Grifols USA LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Grifols USA LLC located?

Grifols USA LLC's physical address in SAM.gov is 2410 Grifols Wy, Los Angeles, CA 90032, USA.

Is Grifols USA LLC registered in SAM.gov?

Yes. Grifols USA LLC's SAM.gov registration is active through July 23, 2027.

Which contract vehicles does Grifols USA LLC hold?

Grifols USA LLC holds a place on 3 federal contract vehicles, including FSS-61-IB.

What is Grifols USA LLC's most recent federal award?

Grifols USA LLC's most recent federal contract award is Prolastin-c liquid,human 1000MG/VIL (36C26026F0037), from Veterans Integrated Service Network 20, on October 1, 2025.

On GovTribe

See Grifols USA LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors